Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...
A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...
Dr. Mazzone and colleagues report on a cell-free DNA fragmentome assay (DELFIscore) for the classification of lung cancer (1). We have concerns and recommendations. Study participants were enrolled ...
Abstract: Lung cancer continues to be a leading cause of cancer-related mortality globally, primarily due to late-stage diagnosis. Non-invasive diagnostic techniques, especially those based on exhaled ...
A new study has found that an advanced CT scan method, called photon-counting CT, may be much better than regular CT scans for people with lung cancer. This new method provides clearer images, lowers ...
Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...
GREENVILLE, S.C. (FOX Carolina) - Lung cancer is the deadliest cancer in the U.S., killing around 130,000 people every year. Doctors say one of the reasons it’s so deadly is because it’s often caught ...
Bristol Myers Squibb (BMY) on Tuesday announced a collaboration with Microsoft (MSFT) to speed up early detection of lung cancer using the tech giant’s artificial intelligence-powered radiology ...
Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. The U.S. tech giant will provide its suite of artificial-intelligence-powered radiology ...
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for ...
LAFAYETTE, La. (KLFY) — Our Lady of Lourdes is now offering patients the latest in lung cancer treatment using AI. The new artificial intelligence-based software and robot-assisted biopsy technology ...